Dr. Donald Arnette was born in New Orleans, Louisiana in 1973. In 1979, his parents relocated to the Dallas, Texas area, where he currently resides. He attended the University of North Texas where he received a Bachelor’s of Science degree in Biology in 1997. Dr. Arnette went on to further his education and was accepted at the University of Texas Southwestern Medical Center at Dallas. It was there that he also performed research projects at Yale School of Medicine. In 2005, he received a Ph.D. from UT Southwestern Medical Center, where he was the first African American male to receive a Ph.D. from the Department of Cellular and Molecular Biology (DCMB). His post-doctoral fellowship in Cardiology, with the department of Human Growth and Development, was led by Nobel Prize winning physicians, Drs. Mike Brown and Joel Goldstein.

Dr. Arnette has committed countless hours researching why cardiovascular disease is more prevalent in minority communities. From 2005 to 2007, he worked with the Dallas Heart Study and the American Heart Association. Dr. Arnette also led the Genetics of Longevity in African Americans Study. He has worked for major pharmaceutical companies, including Bristol Myers Squibb, Dendreon, and Onyx Pharmaceuticals. He currently serves as a Senior Medical Liaison with Amgen Pharmaceuticals. Dr. Arnette has professionally devoted his life to serving patients by helping to develop more effective drugs with minimal side effects.